BrickBio Unveils Powerful Engineered RNA Therapeutic Modification Platform at AACR 2022
BrickBio Highlights Powerful Advantage of the Company’s BrickADCs™, Protein Origami™, and Synthetic Virology™ Platforms BOSTON, April 25, 2022 /PRNewswire/ — BrickBio, the leader in RNA facilitated site- specific protein assembly, presented an invited poster at the annual meeting of the…
Comments Off on BrickBio Unveils Powerful Engineered RNA Therapeutic Modification Platform at AACR 2022